2021
Progression of depression and anxiety symptoms in pregnancies conceived by assisted reproductive technology in the United States
Simoni MK, Gilstad-Hayden K, Naqvi SH, Pal L, Yonkers KA. Progression of depression and anxiety symptoms in pregnancies conceived by assisted reproductive technology in the United States. Journal Of Psychosomatic Obstetrics & Gynecology 2021, 43: 214-223. PMID: 34472405, PMCID: PMC10116357, DOI: 10.1080/0167482x.2021.1971193.Peer-Reviewed Original ResearchConceptsAssisted-reproductive technologyEdinburgh Postnatal Depression ScalePlanned pregnanciesPostnatal Depression ScaleGestational time periodsART pregnanciesProspective cohortPregnant womenWeeks postpartumGeneralized Estimating EquationsObstetrical practiceDepression ScaleDepressive symptomsPregnancyBlue studiesSecondary analysisConception groupMental healthAnxiety subscaleAnxiety symptomsWomenGroup changesSymptomsPrevalenceWeeks
2020
From Stigma to Validation: A Qualitative Assessment of a Novel National Program to Improve Retention of Physician-Scientists with Caregiving Responsibilities
Jones RD, Miller J, Vitous CA, Krenz C, Brady KT, Brown AJ, Daumit GL, Drake AF, Fraser VJ, Hartmann KE, Hochman JS, Girdler S, Kalet AL, Libby AM, Mangurian C, Regensteiner JG, Yonkers K, Jagsi R. From Stigma to Validation: A Qualitative Assessment of a Novel National Program to Improve Retention of Physician-Scientists with Caregiving Responsibilities. Journal Of Women's Health 2020, 29: 1547-1558. PMID: 32286931, PMCID: PMC7864110, DOI: 10.1089/jwh.2019.7999.Peer-Reviewed Original Research
2019
Accuracy of five self‐report screening instruments for substance use in pregnancy
Ondersma SJ, Chang G, Blake‐Lamb T, Gilstad‐Hayden K, Orav J, Beatty JR, Goyert GL, Yonkers KA. Accuracy of five self‐report screening instruments for substance use in pregnancy. Addiction 2019, 114: 1683-1693. PMID: 31216102, PMCID: PMC8407406, DOI: 10.1111/add.14651.Peer-Reviewed Original ResearchMeSH KeywordsAdultAlcohol DrinkingBlack or African AmericanCigarette SmokingFemaleHispanic or LatinoHumansMarijuana UseMass ScreeningOpioid-Related DisordersPregnancyPregnancy ComplicationsSelf ReportSensitivity and SpecificitySubstance Abuse DetectionSubstance-Related DisordersUnited StatesWhite PeopleYoung Adult
2017
CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence Syndrome
Ko JY, Wolicki S, Barfield WD, Patrick SW, Broussard CS, Yonkers KA, Naimon R, Iskander J. CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence Syndrome. MMWR Morbidity And Mortality Weekly Report 2017, 66: 242-245. PMID: 28278146, PMCID: PMC5687191, DOI: 10.15585/mmwr.mm6609a2.Peer-Reviewed Original ResearchConceptsNeonatal abstinence syndromeMedication-assisted treatmentPrescription opioidsAbstinence syndromeCentral nervous system irritabilityDrug withdrawal syndromeOpioid use disorderHours of birthPublic health strategiesGastrointestinal dysfunctionOpioid exposurePain reliefWithdrawal syndromeUtero exposureClinical signsHealth strategiesUse disordersSyndromeOpioidsIllicit useExposurePregnancyDysfunctionInfantsIrritability
2015
Are pregnancy planning and timing associated with preterm or small for gestational age births?
Gariepy AM, Lundsberg LS, Stolar M, Stanwood NL, Yonkers KA. Are pregnancy planning and timing associated with preterm or small for gestational age births? Fertility And Sterility 2015, 104: 1484-1492. PMID: 26364840, PMCID: PMC4663160, DOI: 10.1016/j.fertnstert.2015.08.012.Peer-Reviewed Original ResearchConceptsGestational-age birthsPregnancy planningAge birthGestational ageSignificant associationGestational age infantsProspective cohort studyMedical record abstractionHigh-risk populationMultiple confounding factorsMaternal demographicsCohort studyPreterm birthSingleton pregnanciesRecord abstractionPregnant womenAge infantsRisk factorsPregnancy timingHigh prevalenceLarge cohortPretermMAIN OUTCOMEMedical conditionsOutcome data
2014
Clinical Correlates of Prescription Opioid Analgesic Use in Pregnancy
Smith MV, Costello D, Yonkers KA. Clinical Correlates of Prescription Opioid Analgesic Use in Pregnancy. Maternal And Child Health Journal 2014, 19: 548-556. PMID: 24951127, PMCID: PMC4272915, DOI: 10.1007/s10995-014-1536-6.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnalgesics, OpioidAnxiety DisordersComorbidityDepressive Disorder, MajorDrug PrescriptionsFemaleHumansIllicit DrugsOpioid-Related DisordersPainPregnancyPrevalenceProspective StudiesRegression AnalysisRisk FactorsStress Disorders, Post-TraumaticSurveys and QuestionnairesUnited StatesYoung AdultConceptsNon-opioid usersPregnant womenOpioid analgesicsClinical correlatesPrescription opioid analgesic useComposite International Diagnostic InterviewAnxiety disordersOpioid analgesic useProspective cohort studyUse of opioidsMajor depressive disorderPercent of womenPost-traumatic stress disorderAnalgesic useCohort studyOpioid useMedication useThird trimesterPsychiatric comorbidityDepressive disorderSmoking cigarettesOpioid addictionAmerican CollegeDiagnostic criteriaPregnancy
2013
ISPMD consensus on the management of premenstrual disorders
Nevatte T, O’Brien P, Bäckström T, Brown C, Dennerstein L, Endicott J, Epperson CN, Eriksson E, Freeman EW, Halbreich U, Ismail K, Panay N, Pearlstein T, Rapkin A, Reid R, Rubinow D, Schmidt P, Steiner M, Studd J, Sundström-Poromaa I, Yonkers K, Consensus Group of the International Society for Premenstrual Disorders. ISPMD consensus on the management of premenstrual disorders. Archives Of Women's Mental Health 2013, 16: 279-291. PMID: 23624686, PMCID: PMC3955202, DOI: 10.1007/s00737-013-0346-y.Peer-Reviewed Original ResearchConceptsPremenstrual disordersGonadotropin-releasing hormone agonistSelective serotonin reuptake inhibitorsRole of oophorectomySecond consensus meetingSerotonin reuptake inhibitorsVitex agnus castusCentral nervous activityCognitive behavioral therapySuppress ovulationOral contraceptivesOvulation suppressionReuptake inhibitorsHormone agonistPsychotropic medicationsCalcium supplementsAlternative therapiesConsensus recommendationsSex steroidsConsensus meetingNervous activityConsensus conferenceCareful diagnosisBehavioral therapyAgnus castus
2012
Motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice: a randomized trial for treatment of hazardous substance use in pregnancy and after delivery
Yonkers KA, Forray A, Howell HB, Gotman N, Kershaw T, Rounsaville BJ, Carroll KM. Motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice: a randomized trial for treatment of hazardous substance use in pregnancy and after delivery. General Hospital Psychiatry 2012, 34: 439-449. PMID: 22795046, PMCID: PMC3428516, DOI: 10.1016/j.genhosppsych.2012.06.002.Peer-Reviewed Original ResearchConceptsCognitive behavioral therapyMotivational enhancement therapyMET-CBTEnhancement therapyBehavioral therapySubstance useHazardous substance useBrief advicePregnant substance usersMonths postdeliverySubstance usersHospital outpatient clinicSubstance-using womenWeeks of pregnancySubstance misuseSimilar therapeutic effectsPercentage of daysSelf-reported percentageBiological measuresPreterm birthStudy nursesPrimary outcomeOutpatient clinicPrenatal careTherapeutic effect